[Possibilities and limits of modification of symptoms in the spondylogenous syndrome with psychotropic substances].
D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology; D003975:Diazepam / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D000639:Amitriptyline; D003975:Diazepam
Möglichkeit und Grenzen der Beeinflussbarkeit von Beschwerden beim spondylogenen Syndrom durch psychotrope Substanzen.